1、 de FREITAS K M, ALMEIDA J M, MONTEIRO J C, et al. The effects of cyclosporin A and heteropterys tomentosa on the rat liver[J]. An Acad Bras Cienc,2015, 87(1): 369-379. de FREITAS K M, ALMEIDA J M, MONTEIRO J C, et al. The effects of cyclosporin A and heteropterys tomentosa on the rat liver[J]. An Acad Bras Cienc,2015, 87(1): 369-379.
2、 ARNOLD R, PUSSELL B A, PIANTA T J, et al. Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients[J]. Am J Transplant, 2013, 13(9): 2426-2432. ARNOLD R, PUSSELL B A, PIANTA T J, et al. Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients[J]. Am J Transplant, 2013, 13(9): 2426-2432.
3、 SERENO J, VALA H, NUNES S, et al. Cyclosporine A-induced nephrotoxicity is ameliorated by dose reduction and conversion to sirolimus in the rat[J]. J Physiol Pharmacol,2015,66(2): 285-299. SERENO J, VALA H, NUNES S, et al. Cyclosporine A-induced nephrotoxicity is ameliorated by dose reduction and conversion to sirolimus in the rat[J]. J Physiol Pharmacol,2015,66(2): 285-299.
4、 BORLAK J, NIEHOF M. HNF4alpha and HNF1alpha dysfunction as a molecular rational for cyclosporine induced posttransplantation diabetes mellitus[J]. PLoS One, 2009, 4(3): e4662. BORLAK J, NIEHOF M. HNF4alpha and HNF1alpha dysfunction as a molecular rational for cyclosporine induced posttransplantation diabetes mellitus[J]. PLoS One, 2009, 4(3): e4662.
5、 MANNERING S I, HARRISON L C, WILLIAMSON N A, et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified[J]. J Exp Med,2005, 202(9): 1191-1197. MANNERING S I, HARRISON L C, WILLIAMSON N A, et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified[J]. J Exp Med,2005, 202(9): 1191-1197.
6、 PEREIRA M J, PALMING J, RIZELL M, et al. Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents[J]. J Clin Endocrinol Metab, 2014, 99(10): E1885-1894. PEREIRA M J, PALMING J, RIZELL M, et al. Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents[J]. J Clin Endocrinol Metab, 2014, 99(10): E1885-1894.
7、 SAHAY M, SAHAY R K, NARAYAN G, et al. The effects of cyclosporin A and heteropterys tomentosa on the rat liver[J]. Saudi J Kidney Dis Transpl, 2013,24(5): 897-902. SAHAY M, SAHAY R K, NARAYAN G, et al. The effects of cyclosporin A and heteropterys tomentosa on the rat liver[J]. Saudi J Kidney Dis Transpl, 2013,24(5): 897-902.
8、 CHAKKERA H A, KUDVA Y, KAPLAN B. Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus[J]. Clin Pharmacol Ther,2017, 101(1): 114-120. CHAKKERA H A, KUDVA Y, KAPLAN B. Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus[J]. Clin Pharmacol Ther,2017, 101(1): 114-120.
9、 STILLER C R, DUPRE J, GENT M, et al. Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of disease[J]. J Pediatr,1987, 111(6 Pt 2): 1069-1072. STILLER C R, DUPRE J, GENT M, et al. Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of disease[J]. J Pediatr,1987, 111(6 Pt 2): 1069-1072.
10、 JENNER M, BRADISH G, STILLER C, et al. Cyclosporin a treatment of young children with newly-diagnosed type 1 (insulin-dependent) diabetes mellitus[J]. Diabetologia,199,35(9): 884-888. JENNER M, BRADISH G, STILLER C, et al. Cyclosporin a treatment of young children with newly-diagnosed type 1 (insulin-dependent) diabetes mellitus[J]. Diabetologia,199,35(9): 884-888.
11、 RYDéN A K, WESLEY J D, COPPIETERS K T, et al. Non-antigenic and antigenic interventions in type 1 diabetes[J]. Hum Vaccin Immunother, 2014, 10(4): 838-846. RYDéN A K, WESLEY J D, COPPIETERS K T, et al. Non-antigenic and antigenic interventions in type 1 diabetes[J]. Hum Vaccin Immunother, 2014, 10(4): 838-846.
12、 ?ZBAY L A, SMIDT K, MORTENSEN D M, et al. Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells[J]. Br J Pharmacol, 2011, 162(1): 136-146. ?ZBAY L A, SMIDT K, MORTENSEN D M, et al. Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells[J]. Br J Pharmacol, 2011, 162(1): 136-146.
13、 OETJEN E, BAUN D, BEIMESCHE S, et al. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice[J]. Mol Pharmacol,2003, 63(6): 1289-1295. OETJEN E, BAUN D, BEIMESCHE S, et al. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice[J]. Mol Pharmacol,2003, 63(6): 1289-1295.
14、 TIAN Y F, TSAI C S, LEE P C, et al. New-onset diabetes mellitus in cyclosporine-treated organ transplant patients in Taiwan: interim analysis (6 months) of postmarketing surveillance[J]. Transplant Proc,2012,44(3): 661-666. TIAN Y F, TSAI C S, LEE P C, et al. New-onset diabetes mellitus in cyclosporine-treated organ transplant patients in Taiwan: interim analysis (6 months) of postmarketing surveillance[J]. Transplant Proc,2012,44(3): 661-666.
15、 LI H, RAO A, HOGAN P G. Interaction of calcineurin with substrates and targeting proteins[J]. Trends Cell Biol, 2011, 21(2):91-103. LI H, RAO A, HOGAN P G. Interaction of calcineurin with substrates and targeting proteins[J]. Trends Cell Biol, 2011, 21(2):91-103.
16、 CAILLARD S, EPRINCHARD L, PERRIN P, et al. Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematic screening by oral glucose tolerance test[J]. Transplantation,2011, 91(7):757-764. CAILLARD S, EPRINCHARD L, PERRIN P, et al. Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematic screening by oral glucose tolerance test[J]. Transplantation,2011, 91(7):757-764.
17、 HECKING M, HAIDINGER M, D?LLER D, et al. Early basal insulin therapy decreases new-onset diabetes after renal transplantation[J]. J Am Soc Nephrol, 2012, 23(4):739-749. HECKING M, HAIDINGER M, D?LLER D, et al. Early basal insulin therapy decreases new-onset diabetes after renal transplantation[J]. J Am Soc Nephrol, 2012, 23(4):739-749.
18、 CHAKKERA H A, WEIL E J, CASTRO J, et al. Hyperglycemia during the immediate period after kidney transplantation[J]. Clin J Am Soc Nephrol, 2009, 4(4):853-859. CHAKKERA H A, WEIL E J, CASTRO J, et al. Hyperglycemia during the immediate period after kidney transplantation[J]. Clin J Am Soc Nephrol, 2009, 4(4):853-859.
19、 DAVIDSON J A, WILKINSON A. New-onset diabetes after transplantation 2003 international consensus guidelines: an endocrinologist's view[J]. Diabetes Care, 2004,27(3):805-812. DAVIDSON J A, WILKINSON A. New-onset diabetes after transplantation 2003 international consensus guidelines: an endocrinologist's view[J]. Diabetes Care, 2004,27(3):805-812.
20、 MIYATA H, SATOUH Y, MASHIKO D, et al. Sperm calcineurin inhibition prevents mouse fertility with implications for male contraceptive[J]. Science,2015,350(6259): 442-445. MIYATA H, SATOUH Y, MASHIKO D, et al. Sperm calcineurin inhibition prevents mouse fertility with implications for male contraceptive[J]. Science,2015,350(6259): 442-445.
